Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Guo's Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: a Multicenter Pilot Study(Graft Study)

NCT05754541 is registered in ClinicalTrials.gov with Hangzhou Endonom Medtech Co., Ltd. as lead sponsor.

NCT NCT05754541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05754541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Guo's Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: a Multicenter Pilot Study(Graft Study)
Lead sponsor
Hangzhou Endonom Medtech Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
November 10, 2022
Completion date
December 31, 2025
Enrollment
20 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

aortic aneurysm and dissection